Pancreatic Cancer Research

ResearcherIndiana University HealthNo recent work listed

Stuart Sherman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4268-2586; OpenAlex author ID A5063870524. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 3 papers · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper

Papers 10

  1. Combined Versus Separate Sessions of Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for the Diagnosis and Management of Pancreatic Du… Co-author DOI 10.1007/s10620-020-06564-0↗
  2. Covered and uncovered biliary metal stents provide similar relief of biliary obstruction during neoadjuvant therapy in pancreatic cancer: a randomized trial. First author DOI 10.1016/j.gie.2019.06.032↗
  3. Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study. Co-author DOI 10.1002/ijc.30790↗
  4. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer. Co-author DOI 10.1016/j.canlet.2017.02.019↗
  5. Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1093/aje/kwx168↗
  6. TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis. Co-author DOI 10.18632/oncotarget.3233↗
  7. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile. Co-author DOI 10.1038/ajg.2014.331↗
  8. Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis in Pancreatic Cancer: A Prospective Pilot Study of Safety Using 10 mL versus 20 mL Alcohol. Co-author DOI 10.1155/2013/327036↗
  9. Endoscopic palliation of pancreatic cancer. First author DOI 10.1097/ppo.0b013e3182745ad4↗
  10. A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two? Co-author DOI 10.1016/j.gie.2011.07.073↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Murray Korc · 5 shared papers, 2014–2017 · strength 0.30
  2. Gregory A. Coté · 5 shared papers, 2012–2017 · strength 0.28
  3. Mohammad Al‐Haddad · 3 shared papers, 2011–2021 · strength 0.18
  4. John M. DeWitt · 3 shared papers, 2011–2021 · strength 0.18
  5. Ihab I. El Hajj · 1 shared paper, 2021 · strength 0.12
  6. Jeffrey J. Easler · 1 shared paper, 2021 · strength 0.12
  7. Tuğrul Pürnak · 1 shared paper, 2021 · strength 0.12
  8. Evan L Fogel · 1 shared paper, 2021 · strength 0.12
  9. Jesse Gore · 2 shared papers, 2014–2015 · strength 0.10
  10. Hiroyuki Isayama · 1 shared paper, 2019 · strength 0.09
  11. Guido Costamagna · 1 shared paper, 2019 · strength 0.09
  12. Richard A. Kozarek · 1 shared paper, 2019 · strength 0.09
  13. Jacques M.E. Deviere · 1 shared paper, 2019 · strength 0.09
  14. Dong Wan Seo · 1 shared paper, 2019 · strength 0.09
  15. Yousuke Nakai · 1 shared paper, 2019 · strength 0.09
  16. Kulwinder S. Dua · 1 shared paper, 2019 · strength 0.09
  17. Xianyin Lai · 1 shared paper, 2017 · strength 0.08
  18. Michael Garrett House · 1 shared paper, 2017 · strength 0.08
  19. Julia LeBlanc · 2 shared papers, 2011–2013 · strength 0.06
  20. Kelly E. Craven · 1 shared paper, 2015 · strength 0.05
  21. H. Bas Bueno-de-Mesquita · 1 shared paper, 2017 · strength 0.04
  22. Eric J. Duell · 1 shared paper, 2017 · strength 0.04
  23. Leila Luján‐Barroso · 1 shared paper, 2017 · strength 0.04
  24. Paolo Vineis · 1 shared paper, 2017 · strength 0.04
  25. María‐Dolores Chirlaque · 1 shared paper, 2017 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.